Your browser doesn't support javascript.
loading
Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue.
Litchfield, Kevin; Stanislaw, Stacey; Spain, Lavinia; Gallegos, Lisa L; Rowan, Andrew; Schnidrig, Desiree; Rosenbaum, Heidi; Harle, Alexandre; Au, Lewis; Hill, Samantha M; Tippu, Zayd; Thomas, Jennifer; Thompson, Lisa; Xu, Hang; Horswell, Stuart; Barhoumi, Aoune; Jones, Carol; Leith, Katherine F; Burgess, Daniel L; Watkins, Thomas B K; Lim, Emilia; Birkbak, Nicolai J; Lamy, Philippe; Nordentoft, Iver; Dyrskjøt, Lars; Pickering, Lisa; Hazell, Stephen; Jamal-Hanjani, Mariam; Larkin, James; Swanton, Charles; Alexander, Nelson R; Turajlic, Samra.
Affiliation
  • Litchfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • Stanislaw S; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA.
  • Spain L; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK.
  • Gallegos LL; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA.
  • Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • Schnidrig D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • Rosenbaum H; Roche Sequencing Solutions, Madison, 500 S. Rosa Road, Madison, WI 53719, USA.
  • Harle A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Université de Lorraine, CNRS UMR 7039 CRAN, Institut de Cancérologie de Lorraine, Service de Biopathologie, 54000 Nancy, France.
  • Au L; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK.
  • Hill SM; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA; Department of Cancer Biology, University of Arizona Cancer Center, Tucson, AZ 85724, USA.
  • Tippu Z; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK.
  • Thomas J; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK.
  • Thompson L; The Centre for Molecular Pathology, The Royal Marsden Hospital, London SW3 6JJ, UK.
  • Xu H; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • Horswell S; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London NW1 1AT, UK.
  • Barhoumi A; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA.
  • Jones C; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA.
  • Leith KF; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA.
  • Burgess DL; Roche Sequencing Solutions, Madison, 500 S. Rosa Road, Madison, WI 53719, USA.
  • Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • Lim E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Lamy P; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Nordentoft I; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Pickering L; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK.
  • Hazell S; Histopathology Department, Royal Marsden NHS Foundation Trust, London and Sutton, UK.
  • Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Medical Oncology, University College London Hospitals, London, UK.
  • Larkin J; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK.
  • Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Medical Oncology, University College London Hospitals, Londo
  • Alexander NR; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA. Electronic address: nelson.alexander@roche.com.
  • Turajlic S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK. Electronic address: samra.turajlic@crick.ac.uk.
Cell Rep ; 31(5): 107550, 2020 05 05.
Article in En | MEDLINE | ID: mdl-32375028
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Biomarkers, Tumor / Tumor Burden / High-Throughput Nucleotide Sequencing / Lung Neoplasms Type of study: Guideline Limits: Humans Language: En Journal: Cell Rep Year: 2020 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Biomarkers, Tumor / Tumor Burden / High-Throughput Nucleotide Sequencing / Lung Neoplasms Type of study: Guideline Limits: Humans Language: En Journal: Cell Rep Year: 2020 Type: Article Affiliation country: United kingdom